131 related articles for article (PubMed ID: 32755554)
21. Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model.
Wilson AJ; Barham W; Saskowski J; Tikhomirov O; Chen L; Lee HJ; Yull F; Khabele D
J Ovarian Res; 2013 Sep; 6(1):63. PubMed ID: 24020521
[TBL] [Abstract][Full Text] [Related]
22. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
[TBL] [Abstract][Full Text] [Related]
23. Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.
Yahata T; Mizoguchi M; Kimura A; Orimo T; Toujima S; Kuninaka Y; Nosaka M; Ishida Y; Sasaki I; Fukuda-Ohta Y; Hemmi H; Iwahashi N; Noguchi T; Kaisho T; Kondo T; Ino K
Cancer Sci; 2019 Apr; 110(4):1279-1292. PubMed ID: 30702189
[TBL] [Abstract][Full Text] [Related]
24. MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.
Jiang B; Zhu SJ; Xiao SS; Xue M
Inflammation; 2019 Oct; 42(5):1517-1529. PubMed ID: 31049770
[TBL] [Abstract][Full Text] [Related]
25. Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro.
Yi J; Lin Y; Yicong W; Chengyan L; Shulin Z; Wenjun C
Arch Gynecol Obstet; 2020 Oct; 302(4):1009-1017. PubMed ID: 32748054
[TBL] [Abstract][Full Text] [Related]
26. In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models.
Choi SA; Kwak PA; Kim SK; Park SH; Lee JY; Wang KC; Oh HJ; Kim K; Lee DS; Hwang do W; Phi JH
BMC Cancer; 2016 Sep; 16(1):723. PubMed ID: 27609092
[TBL] [Abstract][Full Text] [Related]
27. Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer.
Shakfa N; Li D; Conseil G; Lightbody ED; Wilson-Sanchez J; Hamade A; Chenard S; Jawa NA; Laight BJ; Afriyie-Asante A; Tyryshkin K; Koebel M; Koti M
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37015760
[TBL] [Abstract][Full Text] [Related]
28. In vivo monitoring of survival and proliferation of hair stem cells in a hair follicle generation animal model.
Eun Kim J; Ahn BC; Won Lee H; Hwang MH; Hyun Shin S; Woo Lee S; Kwan Sung Y; Lee J
Mol Imaging; 2013; 12(5):310-7. PubMed ID: 23759371
[TBL] [Abstract][Full Text] [Related]
29. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
30. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.
Tebbe C; Chhina J; Dar SA; Sarigiannis K; Giri S; Munkarah AR; Rattan R
Oncotarget; 2014 Jul; 5(13):4746-64. PubMed ID: 24970804
[TBL] [Abstract][Full Text] [Related]
31. Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.
Mazzoni M; Mauro G; Erreni M; Romeo P; Minna E; Vizioli MG; Belgiovine C; Rizzetti MG; Pagliardini S; Avigni R; Anania MC; Allavena P; Borrello MG; Greco A
J Exp Clin Cancer Res; 2019 May; 38(1):208. PubMed ID: 31113465
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.
Steitz AM; Steffes A; Finkernagel F; Unger A; Sommerfeld L; Jansen JM; Wagner U; Graumann J; Müller R; Reinartz S
Cell Death Dis; 2020 Apr; 11(4):249. PubMed ID: 32312959
[TBL] [Abstract][Full Text] [Related]
33. The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis.
Li GG; Guo ZZ; Ma XF; Cao N; Geng SN; Zheng YQ; Meng MJ; Lin HH; Han G; Du GJ
Dev Comp Immunol; 2016 Jun; 59():89-98. PubMed ID: 26806760
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic SKOV3 cells stimulate M0 macrophages to differentiate into M2 macrophages and promote the proliferation and migration of ovarian cancer cells by activating the ERK signaling pathway.
Zhang Q; Li H; Mao Y; Wang X; Zhang X; Yu X; Tian J; Lei Z; Li C; Han Q; Suo L; Gao Y; Guo H; Irwin DM; Niu G; Tan H
Int J Mol Med; 2020 Jan; 45(1):10-22. PubMed ID: 31746376
[TBL] [Abstract][Full Text] [Related]
35. Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization.
Mlynska A; Povilaityte E; Zemleckaite I; Zilionyte K; Strioga M; Krasko J; Dobrovolskiene N; Peng MW; Intaite B; Pasukoniene V
Am J Reprod Immunol; 2018 Sep; 80(3):e12996. PubMed ID: 29904979
[TBL] [Abstract][Full Text] [Related]
36. Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironment.
Trenti A; Boscaro C; Tedesco S; Cignarella A; Trevisi L; Bolego C
Biochem Pharmacol; 2018 Aug; 154():414-423. PubMed ID: 29890142
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
Zhang Y; Sime W; Juhas M; Sjölander A
Eur J Cancer; 2013 Oct; 49(15):3320-34. PubMed ID: 23810249
[TBL] [Abstract][Full Text] [Related]
38. Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model.
Lee Y; Kollara A; May T; Brown TJ
J Ovarian Res; 2018 Jul; 11(1):56. PubMed ID: 29973223
[TBL] [Abstract][Full Text] [Related]
39. MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer.
An Y; Yang Q
Life Sci; 2020 Feb; 242():117162. PubMed ID: 31837336
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer stem-like cells elicit the polarization of M2 macrophages.
Zhang Q; Cai DJ; Li B
Mol Med Rep; 2015 Jun; 11(6):4685-93. PubMed ID: 25672286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
